Take Control with Eyepen®

A caring eye for your health

Investors

Stock Information

For further IR information, please 

contact our IR agency, TheInvestor, at:

  •  Unique technology - Disposable Devices instead of new drug – while having a relatively low risk and short device regulatory the market potential is of a new drug 

  •  Promising clinical results – Extensive studies showed positive clinical results on diabetics, more studies are underway

  •  Real Need for Patients, Physicians and Payers – clinical data indicates that the devices can assist patients achieving better glycemic control,